A new study has shed light on a poorly understood therapy developed to treat individuals with autoimmune diseases. The researchers not only revealed the molecular mechanisms behind the therapy, but also identified an optimal strategy that will reduce treatment-associated risks and result in long-term modulation of rogue immune system cells. The work has been published in Nature Communications.
Autoimmune diseases—such as multiple sclerosis, type 1 diabetes and rheumatoid arthritis—are chronic inflammatory conditions that result from the body’s immune cells inappropriately attacking healthy tissues. This happens because the immune system is unable to distinguish between your own tissue and potentially harmful substances……..Read More
Source: Nature Communications